ilmscore | Prediction Details
"we expect heavily waiting of revenues to the fourth quarter as our businesses become more seasonal nature with the potential that a high level of cash collections may carry over into q1 of 25"
By Stock Market Live | July 30, 2024 | Pending
From video
MSFT & AMD EARNINGS 01:55:23 - 01:55:36
Interpreted Prediction
Pfizer (PFE) expects revenues to be heavily weighted towards Q4 2024, with a high level of cash collections potentially carrying over into Q1 2025 due to seasonal business nature.

Prediction Details

Ticker
PFE

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.